
DOI . ORG {
}
Title[redir]:
Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer | Journal of Gastroenterology
Description:
The tumor-suppressive effects of nonsteroidal antiinflammatory drugs (NSAIDs) have been suggested to be due to a reduction in cyclooxygenase (COX)-2 activity, although the effects of COX-2 in the colonic mucosa and in colorectal cancer have not been determined. Ki-67 immunoreactivity in cancers is also attracting attention, as Ki-67 reflects cell proliferation, while p53 immunoreactivity is also of interest, as it reflects the malignancy of colorectal lesions. Accordingly, to determine these correlation, we investigated the distribution and intensity of COX-2, p53 and Ki-67 expression in both cancerous and non-cancerous tissues from patients with sporadic and ulcerative colitis (UC)-associated colorectal cancer. We selected 21 colorectal cancer specimens, obtained by surgical resection or colonoscopic biopsy, from 21 patients, including 3 with UC (13 men and 8 women; aged 42β78 years). Histological examination of hematoxylin and eosin-stained specimens revealed that 9 were well differentiated; 11, moderately differentiated; and 1 was a poorly differentiated adenocarcinoma. We used anti-COX-2, p53, and Ki-67 antisera to perform immunohistochemical staining by the labelled streptavidin biotin method and then assessed and graded the staining intensity and distribution. COX-2 staining was more intense in cancer tissue than in non-cancerous areas. Colorectal cancers associated with UC were not stained intensely. COX-2, p53, and Ki-67 positivity rates in were 38.1%, 38.1%, and 47.6%, respectively. There were no relationships among the distributions or intensities of COX-2, p53, and Ki-67 expression. Our results indicate that colorectal cancer tissues overexpress COX-2, but that there are no relationships between COX-2, p53, and Ki-67 expression, suggesting that COX-2 expression may not be related to cell proliferation or to the grade of malignancy. However, it is necessary to determine whether COX-2 in cancer tissue is involved in carcinogenesis or whether it is simply a product of cancer.
Matching Content Categories {π}
- Health & Fitness
- Education
- Social Networks
Content Management System {π}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of doi.org audience?
ποΈ Massive Traffic: 50M - 100M visitors per month
Based on our best estimate, this website will receive around 80,904,851 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {πΈ}
We see no obvious way the site makes money.
While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.
Keywords {π}
cancer, cox, colorectal, article, access, expression, privacy, cookies, content, journal, information, publish, search, immunoreactivity, open, data, log, research, cyclooxygenase, sakuma, fujimori, hirabayashi, differentiated, staining, related, discover, medicine, springer, optional, analysis, personal, including, parties, policy, find, track, gastroenterology, relationship, march, cite, kazuhiro, takahiro, kaoru, akira, terano, explore, effects, suggested, cancers, reflects,
Topics {βοΈ}
ulcerative colitis month download article/chapter eosin-stained specimens revealed colorectal cancer published colorectal cancer screening privacy choices/manage cookies full article pdf colorectal cancer related subjects european economic area nonsteroidal antiinflammatory drugs independent prognostic factor disease-free survival dokkyo university school ki-67 positivity rates conditions privacy policy article sakuma cancer tissue perform immunohistochemical staining check access instant access accepting optional cookies tumor-suppressive effects poorly differentiated adenocarcinoma takahiro fujimori journal finder publish usage analysis march 1999 volumeΒ 34 article journal article log cancer information colorectal lesions cell proliferation article cite privacy policy personal data colorectal cancers books a cancerous tissues optional cookies manage preferences stained intensely hirabayashi journal publish subscription content similar content ki-67 expression ki-67 antisera data protection
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer
description: The tumor-suppressive effects of nonsteroidal antiinflammatory drugs (NSAIDs) have been suggested to be due to a reduction in cyclooxygenase (COX)-2 activity, although the effects of COX-2 in the colonic mucosa and in colorectal cancer have not been determined. Ki-67 immunoreactivity in cancers is also attracting attention, as Ki-67 reflects cell proliferation, while p53 immunoreactivity is also of interest, as it reflects the malignancy of colorectal lesions. Accordingly, to determine these correlation, we investigated the distribution and intensity of COX-2, p53 and Ki-67 expression in both cancerous and non-cancerous tissues from patients with sporadic and ulcerative colitis (UC)-associated colorectal cancer. We selected 21 colorectal cancer specimens, obtained by surgical resection or colonoscopic biopsy, from 21 patients, including 3 with UC (13 men and 8 women; aged 42β78 years). Histological examination of hematoxylin and eosin-stained specimens revealed that 9 were well differentiated; 11, moderately differentiated; and 1 was a poorly differentiated adenocarcinoma. We used anti-COX-2, p53, and Ki-67 antisera to perform immunohistochemical staining by the labelled streptavidin biotin method and then assessed and graded the staining intensity and distribution. COX-2 staining was more intense in cancer tissue than in non-cancerous areas. Colorectal cancers associated with UC were not stained intensely. COX-2, p53, and Ki-67 positivity rates in were 38.1%, 38.1%, and 47.6%, respectively. There were no relationships among the distributions or intensities of COX-2, p53, and Ki-67 expression. Our results indicate that colorectal cancer tissues overexpress COX-2, but that there are no relationships between COX-2, p53, and Ki-67 expression, suggesting that COX-2 expression may not be related to cell proliferation or to the grade of malignancy. However, it is necessary to determine whether COX-2 in cancer tissue is involved in carcinogenesis or whether it is simply a product of cancer.
datePublished:
dateModified:
pageStart:189
pageEnd:194
sameAs:https://doi.org/10.1007/s005350050242
keywords:
Key words: COX-2
p53
Ki-67
colorectal cancer
Gastroenterology
Hepatology
Abdominal Surgery
Colorectal Surgery
Surgical Oncology
image:
isPartOf:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:34
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Kazuhiro Sakuma
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Takahiro Fujimori
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Kaoru Hirabayashi
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Akira Terano
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer
description: The tumor-suppressive effects of nonsteroidal antiinflammatory drugs (NSAIDs) have been suggested to be due to a reduction in cyclooxygenase (COX)-2 activity, although the effects of COX-2 in the colonic mucosa and in colorectal cancer have not been determined. Ki-67 immunoreactivity in cancers is also attracting attention, as Ki-67 reflects cell proliferation, while p53 immunoreactivity is also of interest, as it reflects the malignancy of colorectal lesions. Accordingly, to determine these correlation, we investigated the distribution and intensity of COX-2, p53 and Ki-67 expression in both cancerous and non-cancerous tissues from patients with sporadic and ulcerative colitis (UC)-associated colorectal cancer. We selected 21 colorectal cancer specimens, obtained by surgical resection or colonoscopic biopsy, from 21 patients, including 3 with UC (13 men and 8 women; aged 42β78 years). Histological examination of hematoxylin and eosin-stained specimens revealed that 9 were well differentiated; 11, moderately differentiated; and 1 was a poorly differentiated adenocarcinoma. We used anti-COX-2, p53, and Ki-67 antisera to perform immunohistochemical staining by the labelled streptavidin biotin method and then assessed and graded the staining intensity and distribution. COX-2 staining was more intense in cancer tissue than in non-cancerous areas. Colorectal cancers associated with UC were not stained intensely. COX-2, p53, and Ki-67 positivity rates in were 38.1%, 38.1%, and 47.6%, respectively. There were no relationships among the distributions or intensities of COX-2, p53, and Ki-67 expression. Our results indicate that colorectal cancer tissues overexpress COX-2, but that there are no relationships between COX-2, p53, and Ki-67 expression, suggesting that COX-2 expression may not be related to cell proliferation or to the grade of malignancy. However, it is necessary to determine whether COX-2 in cancer tissue is involved in carcinogenesis or whether it is simply a product of cancer.
datePublished:
dateModified:
pageStart:189
pageEnd:194
sameAs:https://doi.org/10.1007/s005350050242
keywords:
Key words: COX-2
p53
Ki-67
colorectal cancer
Gastroenterology
Hepatology
Abdominal Surgery
Colorectal Surgery
Surgical Oncology
image:
isPartOf:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:34
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Kazuhiro Sakuma
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Takahiro Fujimori
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Kaoru Hirabayashi
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
type:Person
name:Akira Terano
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Journal of Gastroenterology
issn:
1435-5922
0944-1174
volumeNumber:34
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Kazuhiro Sakuma
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
name:Takahiro Fujimori
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
name:Kaoru Hirabayashi
affiliation:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan
address:
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
type:PostalAddress
type:Organization
name:Akira Terano
affiliation:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan
address:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
type:PostalAddress
type:Organization
PostalAddress:
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
name:Department of Pathology, Dokkyo University School of Medicine, Tochigi, Japan, , JP
name:Second Department of Internal Medicine, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Tochigi 321-0293, Japan, , JP
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {π}(74)
- What are the earnings of https://link.springer.com/privacystatement?
- How much does https://link.springer.com/article/10.1007/s005350050242/#main bring in each month?
- How much does https://link.springer.com pull in?
- Find out how much https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s005350050242 earns monthly
- How much does https://link.springer.com/article/10.1007/s005350050242/#eds-c-header-nav make?
- How much income does https://link.springer.com/journals/ have?
- How much profit does https://www.springernature.com/gp/authors generate?
- How much profit is https://link.springernature.com/home/ making per month?
- What is the earnings of https://link.springer.com/article/10.1007/s005350050242/#eds-c-header-popup-search?
- What's the monthly money flow for https://order.springer.com/public/cart?
- What's the monthly income of https://link.springer.com/article/10.1007/s005350050242/?
- Find out how much https://link.springer.com/article/10.1007/s005350050242/journal/535 earns monthly
- How much profit does https://link.springer.com/article/10.1007/s005350050242/#citeas generate?
- How much does https://link.springer.com/article/10.1007/s005350050242/journal/535/aims-and-scope pull in?
- What's the financial outcome of https://www.editorialmanager.com/joga?
- How much does https://link.springer.com/article/10.1007/s005350050242/#auth-Kazuhiro-Sakuma-A1 bring in each month?
- Profit of https://link.springer.com/article/10.1007/s005350050242/#A1
- https://link.springer.com/article/10.1007/s005350050242/#auth-Takahiro-Fujimori-A2 income
- What is the monthly revenue of https://link.springer.com/article/10.1007/s005350050242/#A2?
- Find out how much https://link.springer.com/article/10.1007/s005350050242/#auth-Kaoru-Hirabayashi-A2 earns monthly
- What's the income generated by https://link.springer.com/article/10.1007/s005350050242/#auth-Akira-Terano-A1 each month?
- How much revenue does https://link.springer.com/article/10.1007/s005350050242/article/10.1007/s005350050242/metrics produce monthly?
- See how much https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs005350050242 makes per month
- Profit of https://link.springer.com/product/springer-plus
- Earnings of https://www.springernature.com/gp/librarians/licensing/agc/journals
- How much revenue does https://link.springer.com/10.1038/s41598-017-05308-x?fromPaywallRec=true bring in?
- Income figures for https://link.springer.com/10.1186/s12885-016-2239-8?fromPaywallRec=true
- Get to know what's the income of https://link.springer.com/10.1186/s12962-018-0104-0?fromPaywallRec=true
- Learn how profitable https://link.springer.com/article/10.1007/s005350050242/subjects/anal-cancer is on a monthly basis
- How profitable is https://link.springer.com/article/10.1007/s005350050242/subjects/colon-cancer?
- What's https://link.springer.com/article/10.1007/s005350050242/subjects/colorectal-cancer's gross income?
- How much profit is https://link.springer.com/article/10.1007/s005350050242/subjects/gastrointestinal-cancer making per month?
- How much money does https://link.springer.com/article/10.1007/s005350050242/subjects/rectal-cancer generate?
- How profitable is https://link.springer.com/article/10.1007/s005350050242/subjects/ulcerative-colitis?
- What's the financial intake of https://link.springer.com/article/10.1007/s005350050242/search?sortBy=newestFirst&dc.creator=Kazuhiro%20Sakuma?
- How profitable is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuhiro%20Sakuma?
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuhiro%20Sakuma%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income of https://link.springer.com/article/10.1007/s005350050242/search?sortBy=newestFirst&dc.creator=Takahiro%20Fujimori?
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Takahiro%20Fujimori?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Takahiro%20Fujimori%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en gross monthly?
- See how much https://link.springer.com/article/10.1007/s005350050242/search?sortBy=newestFirst&dc.creator=Kaoru%20Hirabayashi makes per month
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kaoru%20Hirabayashi earn?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kaoru%20Hirabayashi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the monthly income of https://link.springer.com/article/10.1007/s005350050242/search?sortBy=newestFirst&dc.creator=Akira%20Terano?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akira%20Terano
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akira%20Terano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en net monthly?
- What's the monthly money flow for https://s100.copyright.com/AppDispatchServlet?title=Cyclooxygenase%20%28COX%29-2%20immunoreactivity%20and%20relationship%20to%20p53%20and%20Ki-67%20expression%20in%20colorectal%20cancer&author=Kazuhiro%20Sakuma%20et%20al&contentID=10.1007%2Fs005350050242©right=Springer-Verlag%20Tokyo&publication=0944-1174&publicationDate=1999-03&publisherName=SpringerNature&orderBeanReset=true?
- What's https://citation-needed.springer.com/v2/references/10.1007/s005350050242?format=refman&flavour=citation's gross income?
- Get to know what's the income of https://link.springer.com/article/10.1007/s005350050242/search?query=Key%20words%3A%20COX-2&facet-discipline="Medicine%20%26%20Public%20Health"
- How much profit does https://link.springer.com/article/10.1007/s005350050242/search?query=p53&facet-discipline="Medicine%20%26%20Public%20Health" make?
- Revenue of https://link.springer.com/article/10.1007/s005350050242/search?query=Ki-67&facet-discipline="Medicine%20%26%20Public%20Health"
- Get to know what's the income of https://link.springer.com/article/10.1007/s005350050242/search?query=colorectal%20cancer&facet-discipline="Medicine%20%26%20Public%20Health"
- Monthly income for https://link.springer.com/journals/a/1
- Profit of https://link.springer.com/books/a/1
- How much does https://link.springer.com/journals bring in each month?
- How profitable is https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- What's the revenue for https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- How much income is https://www.springernature.com/gp/products earning monthly?
- How much profit is https://www.springernature.com/gp/librarians making per month?
- How much income does https://www.springernature.com/gp/societies have?
- What's the profit of https://www.springernature.com/gp/partners?
- How much does https://www.springer.com/ gross monthly?
- Monthly income for https://www.nature.com/
- What's the financial outcome of https://www.biomedcentral.com/?
- https://www.palgrave.com/'s financial summary
- How much does https://www.apress.com/ earn?
- What's the profit of https://link.springer.com/brands/discover?
- What's the financial intake of https://www.springernature.com/gp/legal/ccpa?
- What are the earnings of https://www.springernature.com/gp/info/accessibility?
- Learn about the earnings of https://link.springer.com/termsandconditions
- What's the income of https://support.springernature.com/en/support/home?
- Earnings of https://link.springer.com/legal-notice
- What's https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's gross income?
- What's the monthly income of https://www.springernature.com/?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Clipboard.js
- Prism.js
Emails and Hosting {βοΈ}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {π¦}
- Crossref